Price (delayed)
$29.86
Market cap
$169.21B
P/E Ratio
N/A
Dividend/share
$1.67
EPS
-$0.45
Enterprise value
$237.61B
Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United
Highlights
Pfizer's EPS has plunged by 112% YoY
Pfizer's net income has shrunk by 112% YoY
Key stats
What are the main financial stats of PFE
Market
Valuations
Earnings
Shares outstanding
5.67B
Market cap
$169.21B
Enterprise value
$237.61B
Price to book (P/B)
1.93
Price to sales (P/S)
3.04
EV/EBIT
N/A
EV/EBITDA
94.97
EV/Sales
4.27
Revenue
$55.64B
EBIT
-$4.2B
EBITDA
$2.5B
Free cash flow
$4.81B
Per share
Balance sheet
Liquidity
EPS
-$0.45
Free cash flow per share
$0.85
Book value per share
$15.48
Revenue per share
$9.82
TBVPS
$15.27
Total assets
$216.19B
Total liabilities
$128.22B
Debt
$69.45B
Equity
$87.7B
Working capital
-$5.99B
Debt to equity
0.79
Current ratio
0.86
Quick ratio
0.42
Net debt/EBITDA
27.34
Margins
Efficiency
Dividend
EBITDA margin
4.5%
Gross margin
57.7%
Net margin
-4.7%
Operating margin
-7.5%
Return on assets
-1.2%
Return on equity
-2.8%
Return on invested capital
-3.4%
Return on capital employed
-2.4%
Return on sales
-7.5%
Dividend yield
5.59%
DPS
$1.67
Payout ratio
N/A
PFE stock price
How has the Pfizer stock price performed over time
Intraday
0.1%
1 week
0.67%
1 month
5.51%
1 year
-11.24%
YTD
3.72%
QTD
6.72%
Financial performance
How have Pfizer's revenue and profit performed over time
Revenue
$55.64B
Gross profit
$32.13B
Operating income
-$4.16B
Net income
-$2.6B
Gross margin
57.7%
Net margin
-4.7%
The company's operating margin has shrunk by 134% QoQ and by 126% YoY
The operating income has plunged by 133% from the previous quarter and by 118% YoY
PFE's net margin has plunged by 117% YoY
Pfizer's net income has shrunk by 112% YoY
Growth
What is Pfizer's growth rate over time
Valuation
What is Pfizer stock price valuation
P/E
N/A
P/B
1.93
P/S
3.04
EV/EBIT
N/A
EV/EBITDA
94.97
EV/Sales
4.27
Pfizer's EPS has plunged by 112% YoY
PFE's P/B is 31% below its 5-year quarterly average of 2.8 but 7% above its last 4 quarters average of 1.8
Pfizer's equity has decreased by 11% YoY and by 5% QoQ
Pfizer's revenue has decreased by 29% YoY
PFE's P/S is 18% below its 5-year quarterly average of 3.7 but 9% above its last 4 quarters average of 2.8
Efficiency
How efficient is Pfizer business performance
The company's return on invested capital has shrunk by 143% QoQ and by 117% YoY
Pfizer's ROS has plunged by 127% from the previous quarter and by 126% YoY
The ROE has shrunk by 113% YoY
Pfizer's ROA has plunged by 111% YoY
Dividends
What is PFE's dividend history
DPS
$1.67
Dividend yield
5.59%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Pfizer financials performed over time
PFE's total assets is 69% greater than its total liabilities
The quick ratio has plunged by 74% YoY and by 26% from the previous quarter
The current ratio has plunged by 59% YoY and by 18% from the previous quarter
PFE's debt is 21% less than its equity
The debt to equity has grown by 20% YoY and by 5% from the previous quarter
Pfizer's equity has decreased by 11% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.